Cargando…
Ganglioside Metabolism and Parkinson's Disease
Here we advance the hypothesis that Parkinson's disease (PD) is fundamentally a failure of trophic support for specific classes of neurons, primarily catecholaminergic. Evidence from our laboratory provides a framework into which a broad array of findings from many quarters can be integrated in...
Autores principales: | Forsayeth, John, Hadaczek, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807391/ https://www.ncbi.nlm.nih.gov/pubmed/29459819 http://dx.doi.org/10.3389/fnins.2018.00045 |
Ejemplares similares
-
CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson’s disease
por: Wang, Rui, et al.
Publicado: (2023) -
Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy
por: Salegio, Ernesto A., et al.
Publicado: (2014) -
Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease
por: Wang, Rui, et al.
Publicado: (2023) -
Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications
por: Sipione, Simonetta, et al.
Publicado: (2020) -
The Pathological Roles of Ganglioside Metabolism in Alzheimer's Disease: Effects of Gangliosides on Neurogenesis
por: Ariga, Toshio, et al.
Publicado: (2011)